Stomach Neoplasms Clinical Trial
Official title:
Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer. A Phase II Clinical Trial
Patients with gastrointestinal cancer often experience physical deconditioning; this could
lead to an increased risk of complications, especially when they require major abdominal
surgical procedures.
It has been suggested that physical training in the preoperative period could improve their
condition, reducing the risk of complications. Although this topic has been investigated, it
has not been established yet the best short preoperative aerobic exercise program to enhance
the aerobic capacity in patients with gastrointestinal cancer who are going to be to surgical
primary management, and consequently, to help patients dealing with the physiological stress
involved in a surgical intervention.
Main objective:
To determine the efficacy and safety of a 4 weeks preoperative exercise program in patients
with gastrointestinal cancer scheduled for primary surgery.
Materials and methods:
This is a Phase II single arm clinical trial that will include patients between 45 and 70
years, with confirmed gastrointestinal cancer (gastric, hepatic, colon or rectal cancer),
without electrocardiographic abnormalities, and scheduled for primary surgery in 4 weeks or
more since recruitment
All the enrolled patients will receive a basal aerobic capacity assessment with the 6-minute
walk test. Then, two physical therapist will prescribe them a supervised and individualized
aerobic training program in 3 sessions per week during 4 weeks. Each session will last 50
minutes and will increase the heart rate target weekly (from 50% to 70% of the maximum heart
rate). The aerobic exercise will be carried on a treadmill or in a stationary bicycle.
The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute
walk test. The main efficacy outcome will be peak oxygen consumption (VO2 peak) and the
safety outcomes will be exercise-related adverse events and the program adherence.
This protocol was approved by the Instituto Nacional de Cancerología's Ethical Board
Gastrointestinal - origin cancer is one of the most frequent causes of cancer worldwide ; the
primary surgical management is the standard treatment, however, the postoperative
complications rate could be up to 35% . Patients with gastrointestinal - origin cancer often
experience physical deconditioning; this could lead to an increased risk of complications,
especially when they require major abdominal procedures.
It has been suggested that physical training in the preoperative period could improve their
condition, reducing the risk of complications. Although this topic has been investigated, it
has not been established yet the best short preoperative aerobic exercise program to enhance
the aerobic capacity in patients with gastrointestinal cancer who are going to be to surgical
primary management, and consequently, to help patients dealing with the physiological stress
involved in a surgical intervention.
Main objective:
To determine the efficacy and safety of a 4 weeks preoperative exercise program in patients
with gastrointestinal cancer scheduled for primary surgery.
Materials and methods:
This is a Phase II single arm clinical trial that will include patients between 45 and 70
years, with confirmed gastrointestinal cancer (gastric, liver, colon or rectal cancer),
scheduled for surgery in 4 weeks or more since recruitment and without electrocardiographic
abnormalities.
The patients will be selected from the gastrointestinal unit surgical schedule. The eligible
patients will be invited to participate and after their agreement to participate and to do
the informed consent process, they will be scheduled to the basal assessment. This aerobic
capacity assessment will be done with the 6-minute walk test.
After the basal measurement, two physical therapists will prescribe an individualized aerobic
training program in 3 sessions per week during 4 weeks. Each session will last 50 minutes and
will be programmed as follows:
- Week 1: heart rate target: 50% of maximum heart rate
- Week 2: heart rate target: 60% of maximum heart rate
- Week 3: heart rate target: 70% of maximum heart rate
- Week 4: heart rate target: 60% of maximum heart rate
The aerobic exercise will be carried on a treadmill or in a stationary bicycle, according to
the patient's preferences and will be supervised by a physical therapist.
The post intervention aerobic capacity will be measured at week 3 and 4 with the 6-minute
walk test. The main efficacy outcome will be peak oxygen consumption (VO2 peak) and the
safety outcomes will be exercise-related adverse events and the program adherence.
This protocol was approved by the Instituto Nacional de Cancerología's Ethical Board.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01950572 -
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
|
||
Recruiting |
NCT05161572 -
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer
|
Phase 2 | |
Not yet recruiting |
NCT04351867 -
A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer
|
Phase 3 | |
Recruiting |
NCT02887612 -
ctDNA for Prediction of Relapse in Gastric Cancer
|
||
Active, not recruiting |
NCT02930291 -
The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy
|
||
Completed |
NCT02649348 -
Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome
|
N/A | |
Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
Active, not recruiting |
NCT01609309 -
Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)
|
Phase 3 | |
Completed |
NCT00375999 -
Docetaxel and Epirubicin in Advanced Gastric Cancer
|
Phase 2 | |
Completed |
NCT00382720 -
Docetaxel and Oxaliplatin in Gastric Cancer
|
Phase 2 | |
Completed |
NCT00980382 -
A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
Active, not recruiting |
NCT05602935 -
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
|
Phase 2 | |
Recruiting |
NCT05033392 -
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
|
Phase 2 | |
Completed |
NCT04539769 -
Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients With Gastric Cancer and Type 2 Diabetes
|
Phase 2 | |
Active, not recruiting |
NCT02930278 -
The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy
|
||
Active, not recruiting |
NCT02845986 -
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
|
Phase 2 | |
Completed |
NCT02902575 -
The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT04222114 -
Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
|
Phase 3 | |
Recruiting |
NCT05068180 -
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
|
Phase 4 |